Phlebotomy and bolus subcutaneous deferoxamine in Algerian patients with thalassemia major or intermedia or sickle cell disease treated with hydroxyurea

被引：0
|
作者：
Bradai, Mohamed [1 ]
Bachir, Dora [2 ]
De Montalembert, Mariane [3 ]
机构：
[1] Hop Franz Fanon, Serv Hematol, Blida, Algeria
[2] Hop Henri Mondor, Ctr Drepanocytose, F-94010 Creteil, France
[3] Hop Necker Enfants Malad, Serv Pediat Gen, Paris, France
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3812
引用
收藏
页码：20B / 21B
页数：2
相关论文
共 50 条
  • [41] Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
    Di Grazia, Daniela
    Mirabella, Cristina
    Chiara, Francesco
    Caudana, Maura
    Agar, Francesco Maximillian Anthony Shelton
    Zanatta, Marina
    Allegra, Sarah
    Bertello, Jenni
    Voi, Vincenzo
    Ferrero, Giovanni Battista
    Abbadessa, Giuliana
    De Francia, Silvia
    PHARMACEUTICALS, 2024, 17 (10)
  • [42] Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
    Moreira de Oliveira, Emanuel Almeida
    Boy, Kenia de Assis
    Pinho Santos, Ana Paula
    Machado, Carla da Silva
    Velloso-Rodrigues, Cibele
    Almeida Silva Gerheim, Pamela Souza
    Mendonca, Leonardo Meneghin
    EINSTEIN-SAO PAULO, 2019, 17 (04): : eAO4742
  • [43] Thalassemia Major and Sickle Cell Disease in Adolescents and Young Adults
    Yacobovich, Joanne
    Tamary, Hannah
    ACTA HAEMATOLOGICA, 2014, 132 (3-4) : 340 - 347
  • [44] Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease
    Papanikolaou, Eleni
    Anagnou, Nicholas P.
    CURRENT GENE THERAPY, 2010, 10 (05) : 404 - 412
  • [45] Hydroxyurea Dosage Classification for Sickle Cell Disease Patients
    Singh, Bikesh Kumar
    Thakkar, Hardik
    PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON INVENTIVE COMPUTATION TECHNOLOGIES (ICICT 2021), 2021, : 1289 - 1292
  • [46] Semen analysis in patients with sickle cell disease on hydroxyurea
    Wolf, S.
    Barroso, F.
    Kaya, B.
    Telfer, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 125 - 125
  • [47] SERUM IMMUNOGLOBULIN LEVELS IN SICKLE CELL DISEASE AND THALASSEMIA MAJOR
    EVANS, HE
    REINDORF, C
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1968, 116 (06): : 586 - &
  • [48] Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
    Borgna-Pignatti, C
    Cappellini, MD
    De Stefano, P
    Del Vecchio, GC
    Forni, GL
    Gamberini, MR
    Ghilardi, R
    Piga, A
    Romeo, MA
    Zhao, HQ
    Cnaan, A
    BLOOD, 2006, 107 (09) : 3733 - 3737
  • [49] SPINAL DEFORMITIES IN DEFEROXAMINE-TREATED HOMOZYGOUS BETA-THALASSEMIA MAJOR PATIENTS
    HARTKAMP, MJ
    BABYN, PS
    OLIVIERI, F
    PEDIATRIC RADIOLOGY, 1993, 23 (07) : 525 - 528
  • [50] Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major
    Ordonez, Javier
    del Canizo, Agustin
    Belendez, Cristina
    Garcia-Morin, Marina
    Perez-Egido, Laura
    Fanjul, Maria
    Garcia-Casillas, Maria A.
    Cerda, Julio
    Pelaez, David
    Bardon, Eduardo
    de Agustin, Juan C.
    Cela, Elena
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (05) : E655 - E660
12345